Trastuzumab Deruxtecan Authorized in China for HER2-Low Metastatic Breast November 23, 2023July 13, 2023 by QLAX IQ China’s Nationwide Medical Merchandise Administration has authorised fam-trastuzumab deruxtecan-nxki (Enhertu) toRead more